Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 20% ± 4% | |
GABAergic neuron | 3 studies | 37% ± 4% | |
glutamatergic neuron | 3 studies | 35% ± 7% | |
epithelial cell | 3 studies | 19% ± 3% | |
transit amplifying cell | 3 studies | 25% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 235.87 | 1443 / 1445 | 100% | 18.98 | 183 / 183 |
ovary | 100% | 163.83 | 180 / 180 | 100% | 11.97 | 429 / 430 |
intestine | 100% | 450.61 | 966 / 966 | 100% | 31.14 | 525 / 527 |
breast | 100% | 194.42 | 459 / 459 | 99% | 10.47 | 1108 / 1118 |
brain | 99% | 206.47 | 2619 / 2642 | 100% | 10.44 | 704 / 705 |
stomach | 99% | 161.70 | 355 / 359 | 100% | 28.66 | 286 / 286 |
uterus | 100% | 200.91 | 170 / 170 | 98% | 13.73 | 452 / 459 |
bladder | 100% | 188.14 | 21 / 21 | 98% | 17.24 | 496 / 504 |
lung | 100% | 257.07 | 576 / 578 | 99% | 12.18 | 1140 / 1155 |
prostate | 100% | 171.62 | 245 / 245 | 97% | 6.73 | 487 / 502 |
skin | 100% | 269.85 | 1803 / 1809 | 95% | 9.71 | 449 / 472 |
liver | 100% | 213.26 | 226 / 226 | 92% | 8.74 | 372 / 406 |
kidney | 100% | 313.66 | 89 / 89 | 90% | 6.44 | 810 / 901 |
pancreas | 90% | 76.65 | 295 / 328 | 94% | 7.05 | 168 / 178 |
thymus | 99% | 139.43 | 649 / 653 | 69% | 5.73 | 415 / 605 |
adrenal gland | 99% | 119.29 | 256 / 258 | 58% | 2.64 | 134 / 230 |
muscle | 100% | 264.23 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 239.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.80 | 1 / 1 |
adipose | 100% | 193.30 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 121.21 | 1312 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 15.75 | 28 / 29 |
peripheral blood | 94% | 454.40 | 877 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 151.38 | 803 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 66% | 4.03 | 53 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008299 | Biological process | isoprenoid biosynthetic process |
GO_0006744 | Biological process | ubiquinone biosynthetic process |
GO_0032478 | Cellular component | heterotetrameric polyprenyl diphosphate synthase complex |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_1990234 | Cellular component | transferase complex |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0052923 | Molecular function | all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004659 | Molecular function | prenyltransferase activity |
GO_0097269 | Molecular function | all-trans-decaprenyl-diphosphate synthase activity |
Gene name | PDSS1 |
Protein name | Decaprenyl diphosphate synthase subunit 1 All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1) |
Synonyms | TPRT DPS1 |
Description | FUNCTION: Heterotetrameric enzyme that catalyzes the condensation of farnesyl diphosphate (FPP), which acts as a primer, and isopentenyl diphosphate (IPP) to produce prenyl diphosphates of varying chain lengths and participates in the determination of the side chain of ubiquinone . Supplies nona and decaprenyl diphosphate, the precursors for the side chain of the isoprenoid quinones ubiquinone-9 (Q9)and ubiquinone-10 (Q10) respectively . The enzyme adds isopentenyl diphosphate molecules sequentially to farnesyl diphosphate with trans stereochemistry . . |
Accessions | Q5T2R2 ENST00000491711.5 ENST00000376215.10 [Q5T2R2-1] H0YEE6 |